Clinical Trials Logo
  1. Home
  2. Stomach Ulcer
  3. NCT00272467

Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy

Stomach Ulcer Clinical Trial

Official title:
A Comparative Study on the Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy

Clinical Trial Summary

The purpose of this study is to evaluate the ulcer healing efficacy of rebamipide in comparison with omeprazole in Helicobacter pylori-positive gastric ulcer after eradication therapy.

Clinical Trial Description

This study is designed to evaluate the ulcer healing efficacy of rebamipide administered following the eradication therapy in comparison with the well known PPI, omeprazole. This is a double-blind, comparative study which is expected to prove the role of rebamipide in gastric ulcer healing after the eradication therapy. This study may contribute to further clinical research on a new type of ulcer treatment by looking at the treatment modality based on the enhancement of defensive factors. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00272467
Study type Interventional
Source Korea Otsuka International Asia Arab
Contact
Status Completed
Phase Phase 4
Start date July 2005
Completion date April 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT02299687 - Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole Phase 1
Completed NCT00284908 - Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers Phase 1
Completed NCT00239551 - Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer Phase 4
Completed NCT02710994 - Pharmacodynamics and Safety of CDFR0209 Phase 1
Completed NCT01167101 - Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection? N/A
Terminated NCT00762359 - A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers Phase 3
Completed NCT01376414 - H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department N/A
Completed NCT00543868 - MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001) Phase 2
Completed NCT05208268 - A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
Completed NCT02032030 - Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
Completed NCT03060733 - Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Completed NCT03060746 - Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Completed NCT00125736 - A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium Phase 4
Completed NCT00233389 - Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer Phase 4
Terminated NCT00839488 - Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis Phase 4
Completed NCT00787254 - Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs Phase 3
Completed NCT00190255 - Pharmacogenetics of Gastrointestinal Bleeding Phase 4